|
Demographic characteristics and drug susceptibility pattern of isolates in the study |
||||||
| Drug susceptibility pattern |
||||||
|
|
||||||
| Demographic characteristics |
Total |
Susceptible |
Resistant to Isoniazida |
Resistant to Rifampicinb |
MDR |
|
|
|
||||||
| Total no. of strains |
334 |
316 |
13 |
0 |
15 |
|
| Sex |
Women |
163 |
153 |
7 |
0 |
3 |
| Men |
181 |
163 |
6 |
0 |
12 |
|
| History of TB |
New cases |
339 |
311 |
13 |
0 |
15 |
| Retreatment |
5 |
5 |
0 |
0 |
0 |
|
| HIV status |
Positive |
92 |
84 |
5 |
0 |
3 |
| Negative |
176 |
164 |
4 |
0 |
8 |
|
| Unknown |
76 |
68 |
4 |
0 |
4 |
|
| Age group (years) |
18–39 |
267 |
249 |
7 |
0 |
11 |
| 40–60 |
76 |
66 |
6 |
0 |
4 |
|
| >60 |
1 |
1 |
0 |
0 |
0 |
|
|
aResistance to isoniazid other than MDR; bresistance to rifampicin other than MDR; MDR = multidrug resistant strains | ||||||
Asiimwe et al. BMC Infectious Diseases 2008 8:101 doi:10.1186/1471-2334-8-101 |
||||||